Alcohol Use Disorder Clinical Trials in Baltimore, Maryland

9 studies are recruiting for alcohol use disorder in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Environment and Alcohol: A Pilot Study

   Background: Alcohol use disorder (AUD) is a chronic disease that causes more than 140,000 US deaths each year. AUD treatment often includes therapy and medication. Some people with AUD may also benefit from behavioral and lifestyle changes. Objective: To evaluate the effects of different activities…

   Stage

   Phase 1

   Ages

   21 to 100

   Site

   National Institute on Drug Abuse, Baltimore, Maryland

   Run by

   National Institute on Drug Abuse (NIDA)

   See if you can join NCT06860607 on ClinicalTrials.gov

2. A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

   The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with moderate-to-severe Alcohol Use Disorder (AUD). Participation in this study will last approximately 56 weeks.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Maryland Treatment Centers - Mountain Manor Treatment Center, Baltimore, Maryland

   Locations

   118 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07219966 on ClinicalTrials.gov

3. Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

   Background: People who will participate in research studies need to undergo proper screening, evaluation, and assessment (SEA). SEA helps keep those who participate in studies safe. It also helps ensure accurate study results. The National Institute on Drug Abuse (NIDA) Intramural Research Program …

   Stage

   Not phased

   Ages

   18 to 99

   Site

   National Institute on Drug Abuse, Baltimore, Maryland

   Run by

   National Institute on Drug Abuse (NIDA)

   See if you can join NCT06552741 on ClinicalTrials.gov

4. A Study of Brenipatide in Participants With Alcohol Use Disorder

   The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with Alcohol Use Disorder (AUD) and hazardous alcohol use. Participation in this study will last approximately 56 weeks.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Maryland Treatment Centers - Mountain Manor Treatment Center, Baltimore, Maryland

   Locations

   116 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07219953 on ClinicalTrials.gov

5. Spironolactone in Alcohol Use Disorder (SAUD)

   Background: Alcohol use disorder (AUD) affects about 29.5 million people in the United States. Only 3 medicines have been approved by Food and Drug Administration to treat AUD. Researchers want to find better treatments for AUD. Animal studies found that a medicine called spironolactone, may decrea…

   Stage

   Phase 1

   Ages

   21 to 99

   Site

   National Institute on Drug Abuse, Baltimore, Maryland

   Run by

   National Institute on Drug Abuse (NIDA)

   See if you can join NCT05807139 on ClinicalTrials.gov

6. Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH

   Given the severe consequences of alcohol relapse following liver transplantation for alcoholic hepatitis (AH-LT), it is critical to accurately identify alcohol use and implement alcohol interventions early in the post-transplant period to optimize patient outcomes. The proposed randomized clinical …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Johns Hopkins University School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT03845205 on ClinicalTrials.gov

7. Cerebellar Involvement in Alcohol Use Disorder (AUD)

   The goal of this observational and interventional study is to better understand the involvement of the cerebellum in the brain reward system in persons with alcohol use disorder (AUD). The main questions it aims to answer are: 1. What is the nature of cerebellar input to the ventral tegmental area …

   Stage

   Not phased

   Ages

   25 to 55

   Site

   Johns Hopkins University School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT05732207 on ClinicalTrials.gov

8. A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects

   The primary objective of this study is to find the tolerable dose and characterize the safety and pharmacokinetics/ pharmacodynamics (PK/PD) of single and repeated dose of CMND-100 in Healthy Volunteers (HV) and Subjects with Alcohol Use Disorder (AUD). The secondary objective of this study is to p…

   Stage

   Phase 1

   Ages

   18 to 60

   Site

   Johns Hopkins Bayview Medical Center, Baltimore, Maryland

   Locations

   4 in total

   Run by

   Clearmind Medicine Inc.

   See if you can join NCT05913752 on ClinicalTrials.gov

9. Alcohol Research in HIV: Relapse Prevention

   3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Johns Hopkins School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT05163301 on ClinicalTrials.gov